Immunotherapy with Inactivated Virus-Loaded Dendritic Cells in Cats
Author Information
Author(s): Giulia Freer, Donatella Matteucci, Paola Mazzetti, Francesca Tarabella, Enrica Ricci, Leonia Bozzacco, Antonio Merico, Mauro Pistello, Luca Ceccherini-Nelli, Mauro Bendinelli
Primary Institution: Retrovirus Center and Virology Section, Department of Experimental Pathology, University of Pisa
Hypothesis
Can immunotherapy with dendritic cells loaded with inactivated FIV improve immune responses in FIV-infected cats?
Conclusion
The study found that while the immunotherapy increased FIV-specific immune responses, it did not significantly alter the course of FIV infection in the treated cats.
Supporting Evidence
- FIV-specific lymphoproliferative responses were markedly increased after treatment.
- Viral loads and CD4+ T cell depletion were unaffected by the immunotherapy.
- One cat exhibited a dramatic decrease in plasma viremia, but most did not show significant changes.
Takeaway
The researchers tried to help sick cats fight a virus by giving them special immune cells, but it didn't really work as they hoped.
Methodology
The study involved immunotherapy using monocyte-derived dendritic cells loaded with AT2-inactivated FIV, administered to FIV-infected cats over three months.
Limitations
The study had a small sample size and the immunotherapy did not lead to significant changes in viral loads or CD4+ T cell counts.
Participant Demographics
Eleven specific-pathogen-free female cats infected with FIV for 1 to 7 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website